Weiping Zou
Charles B de Nancrede Research Professor of Surgery
Professor of Surgery
Professor of Pathology
Medical School
[email protected]
Available to mentor
Weiping Zou
Professor
Manage Your Profile
Center Memberships
-
Center MemberRogel Cancer Center
-
Center MemberMM-PKUHSC Joint Institute
Recent Publications
-
Singhal R, Zhang NW, Lee ZH, Bell HN, Dalal PJ, Solanki S, Huang W, Rebernick R, Sajjakulnukit P, Jasewicz H, Kumar R, Kotla NK, Huber A, Mallappa AV, Arya SB, Takahashi S, Kasano-Camones CI, Carpenter E, di Magliano MP, Moon JJ, Parent CA, Gonzalez FJ, Patterson AD, Green MD, Zou W, Stoffel EM, Lyssiotis CA, Shah YM. 2026 Apr 6;PreprintFatty acids in the tumor microenvironment reprogram neutrophils to induce immunosuppression via adenosine.
DOI:10.64898/2026.04.02.716169 PMID: 41993509 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipData from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.c.8239507 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S1 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047022 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S2 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047019 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S3 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047016 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S4 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047013 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S5 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047010 -
Griffith BD, Kadiyala P, McGue J, Sun L, Kumar A, Espinoza CE, Donahue KL, Iyer MK, Speyer C, Nelson S, Spiteri A, Elhossiny AM, Brown K, Attebury H, Bednar F, Carpenter ES, Kryczek I, Zhang Y, Zou W, Pasca di Magliano M, Frankel TL. 2026 Jan 12;Additional ScholarshipFigure S6 from Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
DOI:10.1158/2159-8290.31047004
Featured News & Stories
Department News
Xinghao Wang (Zou Lab) Awarded F30 Grant
PhD student Xinghao Wang has been awarded an NIH F30 grant.
Health Lab
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.
Health Lab
Researchers find common immune system mechanism between pregnancy, cancer
Researchers find common immune system mechanism between pregnancy, cancer